Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 5/20 | 0.62 |
| ▸ | TACR1 | P25103 | 1/20 | 0.61 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.59 |
| ▸ | NTSR2 | O95665 | 3/20 | 0.57 |
| ▸ | NTSR1 | P30989 | 3/20 | 0.57 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.56 |
| ▸ | SORT1 | Q99523 | 2/20 | 0.56 |
| ▸ | F2 | P00734 | 1/20 | 0.56 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.55 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.55 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.55 |
| ▸ | NPY1R | P25929 | 1/20 | 0.54 |
| ▸ | NPY2R | P49146 | 1/20 | 0.54 |
| ▸ | NPY4R | P50391 | 1/20 | 0.54 |
| ▸ | GNRHR | P30968 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29772142 | 0.98 | KISS1R (0.64) | KISS1RTACR1C5AR1NTSR2NTSR1 | |
| SCHEMBL31332280 | 0.92 | KISS1R (0.64) | KISS1RTACR1C5AR1NTSR2NTSR1 | |
| SCHEMBL34463648 | 0.91 | KISS1R (0.62) | KISS1RTACR1C5AR1NTSR2NTSR1 | |
| SCHEMBL29598567 | 0.91 | KISS1R (0.65) | KISS1RTACR1C5AR1NTSR2NTSR1 | |
| SCHEMBL31468796 | 0.91 | KISS1R (0.64) | KISS1RC5AR1IL23RNPY1RNPY2R | |
| SCHEMBL29973644 | 0.89 | KISS1R (0.66) | KISS1RC5AR1IL23RNPY1RNPY2R | |
| SCHEMBL29683171 | 0.87 | KISS1R (0.62) | KISS1R | |
| SCHEMBL29660499 | 0.87 | KISS1R (0.65) | KISS1RTACR1C5AR1NTSR2NTSR1 | |
| SCHEMBL31410855 | 0.86 | KISS1R (0.65) | KISS1RC5AR1IL23RNPY1RNPY2R | |
| SCHEMBL30023454 | 0.86 | DPP3 (0.64) | KISS1RC5AR1IL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | LONGEVITY BIOTECH, INC. | 2024-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | SCTR, GIPR, APLNR | KISS1R 1232/4885TACR1 186/4885C5AR1 204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.